Pharmaceutical company
Proposals on patent policy impacting biopharmaceutical innovation. General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
VENN STRATEGIES
1341 G Street NW, 6th Floor, WASHINGTON, DC, 20005, US
SAMUEL GOODSTEIN MICHAEL SPIRA MICHAEL SPIRA EMILIA DISANTO